XRHealth, a company that delivers therapy through virtual reality headsets and other connected devices, has acquired PursueCare, a Middletown, Connecticut provider of virtual addiction treatment. HIT Consultant reported the deal on November 9, 2026, and MobiHealthNews also covered it.
No price or other terms were disclosed.
PursueCare's addiction physicians, psychiatric clinicians, therapists and case managers will become part of XRHealth's network, and its clinical caseload will move onto XRHealth's virtual reality platform, according to HIT Consultant. That platform uses avatar-based group therapy rooms where patients can attend peer recovery circles and counselling sessions anonymously.
What PursueCare does
PursueCare runs telehealth clinics that treat dependence on alcohol, opioids, cannabis, kratom and 7-OH, as well as mental health conditions that often occur alongside addiction. Its services include medical evaluations, medication-assisted treatment such as buprenorphine for opioid use disorder, psychiatric medication management, licensed therapy and case management that helps patients with housing, transport and re-entry after the justice system. Its website lists telehealth services in Connecticut, Kentucky, Maine, New Hampshire, Ohio and West Virginia.
The company also owns RESET and RESET-O, two prescription digital therapeutics originally developed by Pear Therapeutics. RESET delivers cognitive behavioural therapy and contingency management over a 12-week course for adults with substance use disorder, and RESET-O is an 84-day programme used with buprenorphine for adults with opioid use disorder. HIT Consultant described both as FDA-authorised.
PursueCare's leadership page also lists chief of staff Innis Barton, chief compliance officer and corporate counsel Tyler Countie, and clinical director Phyllis Mogielski-Watson. Mercadante has described PursueCare's model as low-barrier services delivered through telehealth.
“Substance use disorders require care that is personalized, continuous, and accessible”
The founder and the funding
PursueCare was founded in 2019 by Nicholas Mercadante, a lawyer who is its chief executive. Its leadership team also includes chief technology officer Steven Varjabedian.
In April 2021 the company raised an oversubscribed $7 million Series A2, bringing its total Series A funding to more than $11 million. OCA Ventures, Seyen Capital, Wasabi Investors and a group of healthcare investors took part. At the time Mercadante said the money would let PursueCare expand its low-barrier services to more patients.
Why XRHealth is buying
XRHealth, founded and led by chief executive Eran Orr, provides immersive virtual care through augmented and virtual reality headsets, smartwatches, smartphones and home devices. PursueCare gives it a clinical team and licensed services in addiction medicine.
Orr told HIT Consultant that substance use disorders require care that is "personalized, continuous, and accessible," and that the aim is for someone struggling with addiction to reach care at the moment they need it.
HIT Consultant cited federal SAMHSA data showing that 44.6 million Americans aged 12 and older had a substance use disorder in 2025, and that 89% of them received no treatment.
XRHealth's platform reaches patients through augmented and virtual reality headsets, smartwatches, smartphones and connected home devices. Orr said the company's vision is to make personalised healthcare more accessible and connected across the devices people use every day, and that PursueCare's clinicians will now work inside that system.
A test for digital therapeutics
The deal puts the two prescription apps inside a clinical service that already treats addiction patients, rather than selling them as standalone products. XRHealth said patients will be able to reach licensed addiction clinicians, therapists, counsellors, psychiatrists and case managers through secure telehealth and mobile services.
XRHealth did not say whether the PursueCare brand will remain or how many staff are joining. Mercadante, who founded PursueCare and still leads it, was not quoted in HIT Consultant's report on the deal, and XRHealth did not say what role he will take.
For patients, the main change will be the option to attend group sessions inside XRHealth's virtual rooms as avatars, which the company says lets people join peer recovery circles without revealing who they are.




